SCHEMBL7110271

SCHEMBL7110271

CN(Cl)C(=O)c1cccnc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.55
GAA P10253 2/20 0.55
APP P05067 1/20 0.55
HCAR3 P49019 1/20 0.55
HCAR2 Q8TDS4 1/20 0.55
HTT P42858 1/20 0.54
HSD17B10 Q99714 7/20 0.54
ALOX15 P16050 2/20 0.54
TSHR P16473 2/20 0.54
TP53 P04637 2/20 0.54
USP2 O75604 1/20 0.54
MAPK1 P28482 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
KDM4E B2RXH2 3/20 0.54
F7 P08709 1/20 0.53
F3 P13726 1/20 0.53
SARM1 Q6SZW1 1/20 0.53
SIRT2 Q8IXJ6 1/20 0.53
SIRT6 Q8N6T7 1/20 0.53
SIRT1 Q96EB6 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29751911 0.85 ALDH1A1 (0.59) ALDH1A1GAAAPPHCAR3HCAR2
SCHEMBL161322 0.85 ALDH1A1 (0.59) ALDH1A1GAAAPPHCAR3HCAR2
SCHEMBL31699264 0.85 ALDH1A1 (0.59) ALDH1A1GAAAPPHCAR3HCAR2
Iodide SCHEMBL27448062 0.83 ALDH1A1 (0.57) ALDH1A1GAAAPPHCAR3HCAR2
Bromide SCHEMBL6550191 0.83 ALDH1A1 (0.57) ALDH1A1GAAAPPHCAR3HCAR2
SCHEMBL29089330 0.83 ALDH1A1 (0.57) ALDH1A1GAAAPPHCAR3HCAR2
Hydrogen Peroxide SCHEMBL28248196 0.83 ALDH1A1 (0.62) ALDH1A1GAAAPPHCAR3HCAR2
SCHEMBL93651 0.83 ALDH1A1 (0.57) ALDH1A1GAAAPPHCAR3HCAR2
Hydrochloric Acid SCHEMBL7835171 0.83 ALDH1A1 (0.57) ALDH1A1GAAAPPHCAR3HCAR2
SCHEMBL12562403 0.81 ALDH1A1 (0.55) ALDH1A1GAAAPPHCAR3HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101888999-B Pyridylmethyl-sulfonamide compounds BASF SE 2013-12-11 CN disclosed
EP-1103546-B1 Process for preparation of pyridine derivatives HOFFMANN LA ROCHE (CH) 2003-10-22 EP disclosed
US-6479483-B2 3,4,6-SUBSTITUTED PYRIDINE DERIVATIVES USEFUL FOR TREATING DEPRESSION AND PAIN, RESULTING FROM INFLAMMATORY CONDITIONS, SUCH AS MIGRAINE, RHEUMATOID ARTHRITIS, ASTHMA AND INFLAMATORY BOWEL DISEASE; NK1 RECEPTOR ANTAGONIST HOFFMANN-LA ROCHE INC. 2002-11-12 US disclosed
US-20020091265-A1 4-phenyl-pyridine derivatives BOS MICHAEL (CA) 2002-07-11 US disclosed
US-6303790-B1 REACTING SUBSTITUTED NICOTINAMIDE WITH GRIGNARD REAGENT, OXIDIZING PRODUCT, REACTING WITH HALO-SUBSTITUTED AROMATIC COMPOUND HOFFMAN-LA ROCHE INC. 2001-10-16 US disclosed
US-6297375-B1 4-phenyl-pyridine derivatives HOFFMANN-LA ROCHE INC. 2001-10-02 US disclosed
EP-1103546-A1 Process for preparation of pyridine derivatives F. HOFFMANN-LA ROCHE AG (CH) 2001-05-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020091265-A1 4-phenyl-pyridine derivatives CBR1, CBR3, HCCS ALDH1A1 1775/4885GAA 4797/4885APP 4787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.